Polycystic ovary syndrome in Central Australia: Diagnosis and screening of cardiometabolic risk and emotional wellbeing

Ellis, Emma; Gibson-Helm, Melanie; Boyle, Jacqueline

doi:10.31128/afp-09-17-4327

Cited by 2 publications

(6 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…35,36 The cohort study was assigned a score of 8 out of a maximum score of 9 (lowest risk of bias) on the NOS (adapted for cohort studies) due to the exposed cohort being a selected group of users. 37 The randomized control study was judged to be at low risk of bias for all domains, and the overall risk of bias was classified as low. Bias assessments for all studies are presented in ►Supplementary 4.…”

Section: Methodological Qualitymentioning

confidence: 99%

“…39 Five studies were conducted in Australia, [28][29][30]37,39 five in the United States, 27,31,32,35,38 two in Sri Lanka, 33,36 and one in New Zealand. 34 Studies involving populations of indigenous women in Australia identified women as either Indigenous Australian, [28][29][30] Aboriginal, 37 or as Aboriginal and Torres Strait Islander. 39 Studies conducted in the United States identified indigenous women as Native American, 27 American Indian, Alaskan Native, 38 or Pima Indian.…”

Section: Characteristics Of Selected Studiesmentioning

confidence: 99%

“…Four studies used retrospective clinical audits of patient records, 27,34,36,38 three studies collected clinical data, 32,35,39 and three used data from community studies. 28,29,33 One study recruited via convenience sampling, 37 while another utilized geographically defined purposive sampling. 31 Recruitment was not reported for one study.…”

Section: Characteristics Of Selected Studiesmentioning

confidence: 99%

“…The study characteristics and PICO framework of the 13 included studies (all English, published between 1981 and 2018) are summarized in ►Table 1. Eight studies (61.5%) had a cross-sectional design, [27][28][29][30][31][32][33][34] while the rest employed a case-control, 35,36 cohort study, 37 RCT, 38 or mixed methods design. 39 Five studies were conducted in Australia, [28][29][30]37,39 five in the United States, 27,31,32,35,38 two in Sri Lanka, 33,36 and one in New Zealand.…”

Section: Characteristics Of Selected Studiesmentioning

confidence: 99%

“…Eight studies (61.5%) had a cross-sectional design, [27][28][29][30][31][32][33][34] while the rest employed a case-control, 35,36 cohort study, 37 RCT, 38 or mixed methods design. 39 Five studies were conducted in Australia, [28][29][30]37,39 five in the United States, 27,31,32,35,38 two in Sri Lanka, 33,36 and one in New Zealand. 34 Studies involving populations of indigenous women in Australia identified women as either Indigenous Australian, [28][29][30] Aboriginal, 37 or as Aboriginal and Torres Strait Islander.…”

Section: Characteristics Of Selected Studiesmentioning

confidence: 99%

See 4 more Smart Citations

The Prevalence of Clinical Characteristics of Polycystic Ovary Syndrome among Indigenous Women: A Systematic Search and Review of the Literature

et al. 2021

View full text Add to dashboard Cite

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive-aged women; however, to date there has been no synthesis of the burden of PCOS specifically among indigenous women. We aimed to systematically identify and collate studies reporting prevalence and clinical features of PCOS among indigenous women worldwide. We performed a comprehensive search of six databases (Ovid MEDLINE, MEDLINE In Process & Other Non-Indexed Citations, EMBASE, EBM reviews, CINAHL, and SCOPUS) supplemented by gray literature searches and the screening of reference lists. A narrative synthesis was conducted. Fourteen studies met inclusion criteria; however, one was excluded as it assessed only children and adolescents younger than 15 years, with limited clinical relevance. Studies examined indigenous women from Australia, Sri Lanka, New Zealand, and the United States. Prevalence of PCOS was reported in only four studies and ranged from 3.05% for women in Sri Lanka to 26% for women in Australia. All included studies reported on at least one clinical feature of PCOS. Of the studies that reported on a comparison group from the same country, there was evidence of more severe features in indigenous women from New Zealand and the United States. The limited evidence available warrants further investigation of the burden of PCOS in indigenous women to build the knowledge base for effective and culturally relevant management of this condition.

show abstract

Section: Methodological Qualitymentioning

confidence: 99%